UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
422.86
-2.12 (-0.50%)
Oct 23, 2026, 12:57 PM EDT - Market open

UnitedHealth Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
15,88412,05614,40522,38120,12017,285
Depreciation & Amortization
2,5592,6612,6992,7722,4002,203
Other Amortization
1,7001,7001,4001,2001,000900
Gain (Loss) on Sale of Assets
-575-6454,977-489-588-
Stock-Based Compensation
1,0199711,0181,059925800
Change in Accounts Receivable
-764-764-1,437-3,114-2,523-1,000
Change in Accounts Payable
1,6651,6652,4633,5161,9641,162
Change in Unearned Revenue
163163-197203126-310
Change in Insurance Reserves / Liabilities
5,8245,8242,5033,4824,0532,701
Change in Other Net Operating Assets
-3,056-4,606-4,140-2,444-1,374-1,031
Other Operating Activities
1,776672513502103-367
Operating Cash Flow
26,19519,69724,20429,06826,20622,343
Operating Cash Flow Growth
24.99%-18.62%-16.73%10.92%17.29%0.76%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,369-3,622-3,499-3,386-2,802-2,454
Sale of Property, Plant & Equipment
5615612,0416853,41415
Cash Acquisitions
-1,611-4,509-13,408-10,136-21,458-4,821
Investment in Securities
-5,782361525-1,777-6,837-1,843
Other Investing Activities
1,168-341-9891-793-1,269
Investing Cash Flow
-11,429-8,685-20,527-15,574-28,476-10,372

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-807-11732-
Long-Term Debt Issued
-2,96917,8116,39414,8196,933
Total Debt Issued
1,3383,77617,8116,40515,5516,933
Total Debt Repaid
-6,125-3,050-3,151-2,125-3,015-4,452
Net Debt Issued (Repaid)
-4,78772614,6604,28012,5362,481
Issuance of Common Stock
8278271,8461,3531,2531,355
Repurchases of Common Stock
-5,031-5,545-9,000-8,000-7,000-5,000
Common Dividends Paid
-8,172-7,916-7,533-6,761-5,991-5,280
Other Financing Activities
1,099264-3,485-2,4013,428-1,011
Financing Cash Flow
-16,064-11,644-3,512-11,5294,226-7,455

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
440-619734-62
Miscellaneous Cash Flow Adjustments
-71-355-219---
Net Cash Flow
-1,365-947-1152,0621,9904,454

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
22,82616,07520,70525,68223,40419,889
Free Cash Flow Growth
31.39%-22.36%-19.38%9.73%17.67%-1.16%
Free Cash Flow Margin
5.07%3.59%5.17%6.91%7.22%6.92%
Free Cash Flow Per Share
25.1817.6422.2927.3824.6420.80
Levered Free Cash Flow
26,50115,37612,58820,85523,75919,251
Unlevered Free Cash Flow
28,91017,87715,02922,88425,06720,288

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4,0304,0303,5943,0351,9451,653
Cash Income Tax Paid
3,7143,7144,6206,0785,2223,966
Change in Working Capital
3,8322,282-8081,6432,2461,522
SEC Filings: 10-K · 10-Q